LETA WHITED: Open Payments
NPI 1881723732 · FRANKLIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 11 payments from 6 companies in 2025. Trend: 2023 $174 · 2024 $253 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $164 |
| Alkermes, Inc. | 2 | $55 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: VRAYLAR, Auvelity, VIVITROL, FANAPT, ARISTADA, ABILIFY ASIMTUFII, CAPLYTA.
Industry payments across KY — which companies pay providers there.
